https://it.marketscreener.com/quotazioni/azione/PHARVARIS-N-V-118621673/attualita/Pharvaris-N-V-presenta-i-dati-clinici-di-Deucrictibant-e-l-analisi-degli-endpoint-per-gli-studi-sul-45535886/?utm_source=telegram&utm_medium=social&utm_campaign=share